ASPI — ASP Isotopes Cashflow Statement
0.000.00%
Last trade - 00:00- $698.76m
- $677.06m
- $23.85m
Annual cashflow statement for ASP Isotopes, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.61 | -4.95 | -16.3 | -32.4 | -160 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 2.27 | 1.97 | 9.67 | 18 | 124 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.238 | 0.034 | 1.16 | -2.62 | -3.63 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.578 | -2.94 | -5.41 | -16.7 | -37.8 |
| Capital Expenditures | -2.99 | -4.47 | -2.33 | -11.4 | -9.65 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -0.122 | 0 | -101 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -2.99 | -4.47 | -2.45 | -11.4 | -111 |
| Financing Cash Flow Items | -0.179 | -1.47 | -0.037 | -1.62 | 4.83 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.5 | 6.64 | 13.4 | 82.5 | 372 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.95 | -0.565 | 5.52 | 54 | 224 |